PMN
|
looks like it uses a roche electrochemiluminescence detector coupled with...
|
PMN
|
Ha, blanco. that guy. what an oversell that was (with respect to...
|
PMN
|
https://neurodegenerative-drug-development.com/about/speakers/ Dr. Cashman...
|
PMN
|
I also found this publication interesting in light of recent complaints by...
|
PMN
|
I was happy to see more documentation via the prospectus that PM310 is...
|
PMN
|
There is an interesting comment about PMN310 on the bottom of PG 14...
|
PMN
|
https://www.alzforum.org/news/research-news/plasma-av-test-wins-approval-are...
|
PMN
|
https://kantarobio.com/kantaro-receives-fda-emergency-use-authorization-for...
|
PMN
|
wow, sona tech's market cap went up to almost $1B in a short time period....
|
PMN
|
The corporate overview presentation could use some serious updating. ...
|
PMN
|
Regarding aducanumab, two wild cards to consider. 1. Updcoming change in...
|
PMN
|
Yes, I am aware of these issues. Thank you. I just think the...
|
PMN
|
After reading about aducanumab, I suspect that it has reached the end of the...
|
PMN
|
https://www.alzforum.org/news/research-news/aducanumab-still-needs-prove...
|
PMN
|
Also in that great review paper, a nod to PROMIS: "The next generation...
|
PMN
|
I went back to this review paper at: https://alzres.biomedcentral.com...
|
PMN
|
Has anyone seen any data (binding, selectivity) for PMN310 vs BAN2401, ever? ...
|
PMN
|
I suddenly have a better understanding of why stock trolls exist. Maybe...
|
PMN
|
This is very encouraging so long as the 'seeds' that they mention are...
|
PMN
|
Aside from the cheerleading by PMN for aducanumab, and the perhaps worse than...
|